Next Article in Journal
Evaluation of Oxytetracycline Metabolites Cross-Reactivity with Oxytetracycline Enzyme-Linked Immunosorbent Assay (ELISA)
Previous Article in Journal
Antimicrobial Activity of Silver-Treated Bacteria against other Multi-Drug Resistant Pathogens in Their Environment
Open AccessArticle

Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells

1
Stratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands
2
Department of Pathology and Medical Biology, University of Groningen Medical Center, Hanzeplein 1, 9700 RB Groningen, The Netherlands
*
Author to whom correspondence should be addressed.
Authors contributed equally to the manuscript.
Antibiotics 2020, 9(4), 182; https://doi.org/10.3390/antibiotics9040182
Received: 13 March 2020 / Revised: 31 March 2020 / Accepted: 10 April 2020 / Published: 15 April 2020
(This article belongs to the Section Antibiotic Biosynthesis)
With the increasing resistance of bacteria to current antibiotics, novel compounds are urgently needed to treat bacterial infections. Streptozotocin (STZ) is a natural product that has broad-spectrum antibiotic activity, albeit with limited use because of its toxicity to pancreatic β cells. In an attempt to derivatize STZ through structural modification at the C3 position, we performed the synthesis of three novel STZ analogues by making use of our recently developed regioselective oxidation protocol. Keto-STZ (2) shows the highest inhibition of bacterial growth (minimum inhibitory concentration (MIC) and viability assays), but is also the most cytotoxic compound. Pre-sensitizing the bacteria with GlcNAc increased the antimicrobial effect, but did not result in complete killing. Interestingly, allo-STZ (3) revealed moderate concentration-dependent antimicrobial activity and no cytotoxicity towards β cells, and deoxy-STZ (4) showed no activity at all. View Full-Text
Keywords: antibiotics; regioselective oxidation; streptozotocin; β cells antibiotics; regioselective oxidation; streptozotocin; β cells
Show Figures

Graphical abstract

MDPI and ACS Style

Zhang, J.; Yakovlieva, L.; de Haan, B.J.; de Vos, P.; Minnaard, A.J.; Witte, M.D.; Walvoort, M.T.C. Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells. Antibiotics 2020, 9, 182. https://doi.org/10.3390/antibiotics9040182

AMA Style

Zhang J, Yakovlieva L, de Haan BJ, de Vos P, Minnaard AJ, Witte MD, Walvoort MTC. Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells. Antibiotics. 2020; 9(4):182. https://doi.org/10.3390/antibiotics9040182

Chicago/Turabian Style

Zhang, Ji; Yakovlieva, Liubov; de Haan, Bart J.; de Vos, Paul; Minnaard, Adriaan J.; Witte, Martin D.; Walvoort, Marthe T.C. 2020. "Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells" Antibiotics 9, no. 4: 182. https://doi.org/10.3390/antibiotics9040182

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop